ConnollySD, BernsteinGA, Work Group on QualityIssues: Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry, 46:267–283, 2007.
2.
SeboldC, SoileauB, HeardP, CarterE, O'DonnellL, HaleDE, CodyJD: Whole arm deletions of 18p: Medical and developmental effects. Am J Med Genet Part A, 167A:313–323, 2015.
WangZ, WhitesideSH, SimL, et al.: Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood anxiety disorders: A systematic review and meta-analysis. JAMA Pediatr, 171:1049–1056, 2017.
5.
WilloughbyBL, FaveroM, MochidaGH, BraatenEB: Neuropsychological function in a child with 18p deletion syndrome: A case report. Cogn Behav Neurol, 27:160–165, 2014.
6.
ZavalaJ, RamirezM, MedinaR, HeardP, CarterE, CrandallA, HaleD, CodyJ, EscamillaM: Psychiatric syndromes in individuals with chromosome 18 abnormalities. Am J Med Genet Part B, 153B:837–845, 2010.
